References
- Ali, Z., Sharma, P.K., and Warsi, M.H., 2016. Fabrication and evaluation of ketorolac loaded cubosome for ocular drug delivery. Journal of applied pharmaceutical science, 6, 204–208.
- Andrzejowski, P., and Carroll, W., 2016. Salbutamol in paediatrics: pharmacology, prescribing and controversies. Archives of disease in childhood. Education and practice edition, 101 (4), 194–197.
- Barriga, H.M., Holme, M.N., and Stevens, M.M., 2019. Cubosomes: the next generation of smart lipid nanoparticles? Angewandte chemie (International ed. in English), 58 (10), 2958–2978.
- Bei, D., et al., 2010. Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization. AAPS pharmscitech, 11 (3), 1243–1249.
- Bendas, E.R., and Tadros, M.I., 2007. Enhanced transdermal delivery of salbutamol sulfate via ethosomes. aaps pharmscitech, 8 (4), 213–220.
- Boge, L., et al., 2019. Cubosomes for topical delivery of the antimicrobial peptide LL-37. European journal of pharmaceutics and biopharmaceutics, 134, 60–67.
- Chamieh, J., et al., 2017. Limits in size of Taylor dispersion analysis: representation of the different hydrodynamic regimes and application to the size-characterization of cubosomes. Analytical chemistry, 89 (24), 13487–13493.
- Chen, Y., Ma, P., and Gui, S., 2014. Cubic and hexagonal liquid crystals as drug delivery systems. BioMed research international, 2014, 815981–815910.
- Chime, S.A., and Onyishi, I.V., 2013. Lipid-based drug delivery systems (LDDS): recent advances and applications of lipids in drug delivery. African journal of pharmacy and pharmacology, 7 (48), 3034–3059.
- Das, B., Nayak, A.K., and Nanda, U., 2013. Topical gels of lidocaine HCl using cashew gum and Carbopol 940: preparation and in vitro skin permeation. International journal of biological macromolecules, 62, 514–517.
- de Araújo, D.R., Ribeiro, L. N. d M., and de Paula, E., 2019. Lipid-based carriers for the delivery of local anesthetics. Expert opinion on drug delivery, 16 (7), 701–714.
- Escobar-Chávez, J.J., et al., 2012. Nanocarriers for transdermal drug delivery. Research reports in transdermal drug delivery, 1, 1–13.
- Esposito, E., et al., 2005. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharmaceutical research, 22 (12), 2163–2173.
- Estracanholli, É.A., et al., 2014. Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies. AAPS pharmscitech, 15 (6), 1468–1475.
- Fernandes, M., Simon, L., and Loney, N.W., 2005. Mathematical modeling of transdermal drug-delivery systems: analysis and applications. Journal of membrane science, 256, 184–192.
- Fornasier, M., et al., 2020. Cubosomes stabilized by a polyphosphoester-analog of Pluronic F127 with reduced cytotoxicity. Journal of colloid and interface science, 580, 286–297.
- Freitas, C., and Müller, R.H., 1998. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. International journal of pharmaceutics, 168 (2), 221–229.
- Froelich, A., et al., 2019. Design and study of poloxamer-based microemulsion gels with naproxen. Colloids and surfaces A: physicochemical and engineering aspects, 562, 101–112.
- Gaballa, S.A., El Garhy, O.H., and Abdelkader, H., 2020. Cubosomes: composition, preparation, and drug delivery applications. Journal of advanced biomedical pharmaceutical sciences, 3, 1–9.
- Hamed, R., et al., 2016. Correlation between rheological properties and in vitro drug release from penetration enhancer-loaded Carbopol® gels. Journal of pharmaceutical innovation, 11 (4), 339–351.
- Honary, S., and Zahir, F., 2013. Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2). Tropical journal of pharmaceutical research, 12 (2), 265–273.
- Ijaz, H., et al., 2018. Lipid particulate drug delivery systems: a review. Bioinspired, biomimetic nanobiomaterials, 7 (2), 109–121.
- Ishii, S., et al., 2013. Correlation study in skin and eye irritation between rabbits and humans based on published literatures. Food and chemical toxicology, 55, 596–601.
- Karami, Z., and Hamidi, M., 2016. Cubosomes: remarkable drug delivery potential. Drug discovery today, 21 (5), 789–801.
- Kaur, S.D., et al., 2021. Cubosomes as potential nanocarrier for drug delivery: A comprehensive review. Journal of pharmaceutical research international, 21, 118–135.
- Kim, J.-K., and Lawler, D.F., 2005. Characteristics of zeta potential distribution in silica particles. Bulletin of the korean chemical society, 26, 1083–1089.
- Kurosawa, N., et al., 1993. [Comparison of bioavailability of salbutamol between oral and rectal administration in rabbits]. Yakugaku zasshi, 113 (4), 321–326.
- Lalloo, U., et al., 2007. Guidelines for the management of chronic asthma in adolescents and adults: CPD. South African family practice, 49 (5), 19–31.
- Li, J.-C., et al., 2015. Self-assembled cubic liquid crystalline nanoparticles for transdermal delivery of paeonol. Medical science monitor, 21, 3298–3310.
- Malheiros, B., et al., 2021. Influence of hexadecylphosphocholine (Miltefosine) in phytantriol-based cubosomes: a structural investigation. Colloids surfaces A: Physicochemical engineering aspects, 632, 127720.
- Mansour, M., et al., 2021. Delineating the usage of dexamethasone-loaded cubosomes as a therapeutic armamentarium for hearing loss versus its protective effect: In-vitro and in-vivo animal study. Journal of drug delivery science and technology, 61, 102244.
- Mendes, I., et al., 2019. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil. Colloids and surfaces. B, biointerfaces, 177, 274–281.
- Morgan, D., et al., 1986. Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. British journal of clinical pharmacology, 22 (5), 587–593.
- Murthy, S.N., and Hiremath, S.R., 2004. Clinical pharmacokinetic and pharmacodynamic evaluation of transdermal drug delivery systems of salbutamol sulfate. International journal of pharmaceutics, 287 (1-2), 47–53.
- Murthy, S.N., Rani, S., and Hiremath, R., 2001. Formulation and evaluation of controlled-release transdermal patches of theophylline-salbutamol sulfate. Drug development and industrial pharmacy, 27 (10), 1057–1062.
- Nakano, M., et al., 2001. Small-angle X-ray scattering and 13C NMR investigation on the internal structure of “cubosomes”. Langmuir, 17 (13), 3917–3922.
- Nithya, R., Jerold, P., and Siram, K., 2018. Cubosomes of dapsone enhanced permeation across the skin. Journal of drug delivery science and technology, 48, 75–81.
- Norlén, L., and Al-Amoudi, A., 2004. Stratum corneum keratin structure, function, and formation: the cubic rod-packing and membrane templating model. Journal of investigative dermatology, 123 (4), 715–732.
- Pan, X., et al., 2013. Nanostructured cubosomes as advanced drug delivery system. Current pharmaceutical design, 19 (35), 6290–6297.
- Pond, S.M., and Tozer, T.N., 1984. First-pass elimination basic concepts and clinical consequences. Clinical pharmacokinetics, 9 (1), 1–25.
- Prashar, D., and Sharma, D., 2011. Cubosomes: a sustained drug delivery carrier. Asian journal of research in pharmaceutical science, 1, 59–62.
- Rabiei, M., et al., 2020. Nanomaterial and advanced technologies in transdermal drug delivery. Journal of drug targeting, 28 (4), 356–367.
- Rao, S.V., Sravya, B.N., and Padmalatha, K., 2018. A review on cubosome: The novel drug delivery system. GSC biological pharmaceutical sciences, 5, 1–10.
- Rapalli, V.K., et al., 2021. QbD-driven formulation development and evaluation of topical hydrogel containing ketoconazole loaded cubosomes. Materials science & engineering: C, 119, 111548.
- Rapalli, V.K., et al., 2020. Insights of lyotropic liquid crystals in topical drug delivery for targeting various skin disorders. Journal of molecular liquids, 315, 113771.
- Rizwan, S., et al., 2007. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). Micron (oxford, England: 1993), 38 (5), 478–485.
- Duttagupta, S. A., et al., 2016. Cubosomes: innovative nanostructures for drug delivery. Current drug delivery, 13 (4), 482–493.
- Said, M., et al., 2021. Central composite optimization of ocular mucoadhesive cubosomes for enhanced bioavailability and controlled delivery of voriconazole. Journal of drug delivery science and technology, 61, 102075.
- Salah, S., Mahmoud, A.A., and Kamel, A.O., 2017. Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies. Drug delivery, 24 (1), 846–856.
- Sears, M.R., and Lötvall, J., 2005. Past, present and future. —β2-adrenoceptor agonists in asthma management. Respiratory medicine, 99 (2), 152–170.
- Shabbir, M., et al., 2020. Lipid vesicles and nanoparticles for non-invasive topical and transdermal drug delivery. Current pharmaceutical design, 26 (18), 2149–2166.
- Tan, X., et al., 2012. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert opinion on drug delivery, 9 (10), 1263–1271.
- Tanwar, Y., 2005. Formulation and evaluation of transdermal films of salbutamol sulphate. Dhaka univ J pharm sci, 4, 93–97.
- Wavikar, P., and Vavia, P., 2013. Nanolipidgel for enhanced skin deposition and improved antifungal activity. AAPS pharmscitech, 14 (1), 222–233.
- Younes, N.F., Abdel-Halim, S.A., and Elassasy, A.I., 2018. Corneal targeted Sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. International journal of pharmaceutics, 553 (1–2), 386–397.
- Yousuf, M., et al., 2013. Ketotifen fumarate and salbutamol sulphate combined transdermal patch formulations: In vitro release and Ex vivo permeation studies. Indian journal of pharmaceutical sciences, 75 (5), 569–577.
- Zhou, X., et al., 2018. Nano-formulations for transdermal drug delivery: a review. Chinese chemical letters, 29 (12), 1713–1724.